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Abstract: Nuclear protein-1 (NUPR1) is a small nuclear protein that is responsive to various stress stimuli. Although 
NUPR1 has been associated with cancer development, its expression and roles in cholangiocarcinoma have not yet been 
described. In the present study, we found that NUPR1 was over-expressed in human cholangiocarcinoma tissues, using 
immunohistochemistry. The role of NUPR1 in cholangiocarcinoma was examined by its specific siRNA. NUPR1 siRNA 
decreased proliferation, migration and invasion of human cholangiocarcinoma cell lines (HuCCT1 and SNU1196 cells). From 
these results, we conclude that NUPR1 is over-expressed in cholangiocarcinoma and regulates the proliferation and motility of 
cancer cells.
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ho  mo  logs, suggests that it plays a critical role in acquired 
pathological conditions [2, 15]. 
Structurally, human NUPR1 encodes an 82 aminoacid 
poly  peptide with a theoretical molecular mass of 8,872.7 
Da [16]. Alternative splicing produces two isoform: a and b. 
Iso  form a has 18 additional amino acids whose functional 
significance is not yet known [1]. At its N-terminal, it has 
a PEST domain, suggesting regulation by the ubiquitin/
proteasome system [17]. Its C-terminal has a basic helix-loop-
helix motif [17]. Th   e absence of a stable secondary structure 
of NUPR1, as shown by nuclear magnetic resonance and 
circular dichroism analyses, suggests that it functions by 
interacting with other molecules [18]. For example, NUPR1 
binds to and is acetylated by the general coactivator of 
transcription p300 [19]. 
NUPR1 has been shown to be involved in tumorigenesis. 
Several studies have suggested the role of NUPR1 in the 
proliferation of cancer cells. Forced over-expression of 
NUPR1 increased proliferation of pancreatic cancer-derived 
and HeLa cells [4, 16]. Moreover down-regulation of NUPR1 
decreased colony-formation of pancreatic cancer-derived 
cells [20]. Furthermore, transformed p8
+/+ cells formed 
Introduction
Nuclear protein-1 (NUPR1/Com1/p8) is a small nuclear 
protein that is responsive to various stress stimuli [1-3]. During 
the acute phase of pancreatitis, it is reported to be induced 
in pancreatic acinar cells [4]. Later studies have shown that 
various kinds of injuries such as systemic lipopolysaccharides 
or CCl4 treatments [5, 6], demyelinating agents [7], serum 
withdrawal [8], and cell cycle arrest [9] may cause NUPR1 
induction. Moreover, many molecules such as transforming 
growth factor β  [10], tumor necrosis factor α [11], glucose 
[12], cannabinoids [13], angiotensin [14] and endothelin [14], 
have been shown to induce NUPR1 expresssion. Th   e lack of 
prominent phenotypes in NUPR1 knockout mice, despite 
the fact that it is a single copy gene and has no apparent Anat Cell Biol 2012;45:17-25 Ki-Sun Kim, et al 18
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colonies at high frequency in soft   agar assay [21]. By contrast, 
transformed p8
-/- cells were not able to form colonies. An 
involvement of NUPR1 in metastasis of cancer cells has also 
been suggested. NUPR1 was signifi  cantly up-regulated in the 
metastasis formed in the central nervous system aft  er injec-
tion of breast cancer cells, suggesting that it facilitates tumor 
establishment in a secondary organ [22, 23]. Moreover, the 
NUPR1 expression level was directly linked to lymph node 
metastasis in thyroid cancer [24]. Furthermore, a recent study 
showed that NUPR1 regulates motility of pancreatic cancer 
cells [20]. 
Cholangiocarcinoma is a malignant tumor originating 
from bile duct epithelial cells [25]. Depending on location, 
it can be classified as intrahepatic or extrahepatic. Klatskin 
tumors, which originate from the bifurcation of the hepatic 
duct, are generally considered extrahepatic. Intrahepatic 
cholangiocarcinoma is the second most common primary 
hepatic malignancy worldwide [26]. The main cause of 
cholangiocarcinoma in Asian countries has been associated 
with infections, especially infections with the liver flukes 
Clonorchis sinensis [27, 28]. Despite advances in surgical 
and medical therapy, its survival rate is still poor. The main 
reasons for this poor prognosis are diagnostic difficulty, ex-
tensive local tumor invasion at diagnosis and multi-drug 
resis  tance. Molecular and pathophysiological understanding 
of the disease will improve the diagnosis and prognosis.
The expression status and role of NUPR1 in cholan  gio  car-
cinoma has not yet been examined. In the present study, 
we showed that NUPR1 was over-expressed in cholan  gio-
carcinoma and could regulate motility of cancer cells. 
Materials and Methods
Cell culture and transfection
HuCCT1 and SUN1196 cell line were purchased from 
the Health Science Research Resources Bank (Osaka, Japan) 
and the Korean Cell Line Bank (Seoul, Korea) respec-
tively. HuCCT1 and SNU1196 cells were cultured with 
RPMI1640, 10% fetal bovine serum (FBS) and 1× penicillin/
streptomycin at 37  °C and 5% CO2 incubator. NUPR1 siRNA 
(Bioneer, Daejeon, Korea) and scrambled (SCR) siRNA 
(Dhamacon, Lafayette, CO, USA) were purchased. Cells were 
transfected with 100 nM of NUPR1 siRNA, or SCR siRNA 
with Dhamafect reagent (Dhamacon) in accordance with 
manufacturer protocol. SCR siRNA was used as a negative 
control. The sequences of NUPR1 siRNA duplex were as 
follows: 5'-CAG ACA AAG CGU UAG GAG A-3', 5'-CAG 
AGA CAG ACA AAG CGU U-3', and 5'-CUC CAA CCC 
UAG CAA AAG U-3'.
Immunohistochemistry
After deparaffinization and rehydration, slides were sub-
jected to 0.3% hydrogen peroxide for 30 minutes to quench 
endogenous peroxidase activity. Blocking was performed with 
10% normal donkey serum, 1% bovine serum albumin (BSA) 
in 1× phosphate buff  ered saline (PBS). Anti-NUPR1 antibody 
(Abcam, Cambridge, UK) binding was performed at 1 : 200 
dilution in blocking buffer overnight at 4°C, and secondary 
antibody (1 : 200, horseradish peroxidase [HRP]-conjugated 
anti-rabbit) binding for two hours at room temperature, 
detection with HRP (Vector Laboratories, Burlingame, CA, 
USA) using the DAB substrate kit (Vector Laboratories). 
Reverse transcription polymerase chain reaction (RT-
PCR)
Total RNA was extracted using RNeasy Mini kit (Qiagen, 
Valencia, CA, USA) in accordance with manufacturer pro-
tocol. cDNA was synthesized with MMLV reverse tran-
scriptase (Promega, Madison, WI, USA), dNTP and oligo-
dT primers. Then, PCR was carried out using the following 
primers: NUPR1 (F: 5'-CAC CTT CCC ACC AGC AAC CAG 
CG-3', R: 5'-GTG GGC ATA GGC ATG ATG AGA GGC CC-
3'), and β-actin (F: 5'-CAA GAG ATG GCC ACG GCT GC-
3', R: 5'-TCC TTC TGC ATC CTG TCG GC-3'). β-actin was 
used as a loading control and all signals were normalized to 
β-actin. 
Western blotting
Cell lysates were run onto 10% sodium dodecyl sulfate 
polyacrylamide gel and transferred to a PVDF membrane. 
Blocking was carried out with 3% BSA in PBS for 1 hour at 
room temperature. NUPR1 antibody (Abcam, Cambridge, 
UK) was diluted to 1 : 500 in 3% BSA in PBS, and incubated 
overnight at 4°C. β-actin antibody (Abcam, Cambridge, 
MA, USA) was diluted to 1 : 2,000 in 3% BSA in PBS. HRP-
conjugated secondary antibody (Jackson ImmunoResearch 
Laboratories, West Grove, PA, USA) was diluted to 1 : 2,000 
in PBST and incubated for 2 hours at room temperature. Blots 
were visualized by enhanced chemiluminescence (Amersham 
Bioscience, Freiburg, Ger  many). NUPR1 in cholangiocarcinoma cells
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Proliferation assay
Three or seven days after the transfection of NUPR1 
siRNA into cells in a 96-well plate, 10 μl of Ez-Cytox 
(ITSBIO, Seoul, Korea) were added and incubated for 2 
hours under normal cell culture conditions. Cell viability 
was measured by absorbance at 450 nm using an enzyme-
linked immunosorbent assay reader (TECAN, Mannedorf, 
Switzerland). 
Boyden chamber assay
A modifi  ed Boyden chamber (Neuro Probe, Gaithersburg, 
MD, USA) migration assay was used. Th   e 8.0 μm pore poly-
carbonate filter was coated with type-I collagen (10 μl/ml). 
Two days aft  er transfection with SCR or NUPR1 siRNA, the 
cells were trypsinized. Cells suspended in 30 μl of serum-free 
medium were added to the upper chamber with a density of 
5×10
4 cells per well. Th   e lower chamber was fi  lled with 30 μl 
of medium containing 10% FBS or 100 ng/ml of epidermal 
growth factor (EGF) as chemoattractant. Aft  er treatment with 
mitomycin C at 5 μg/ml (Sigma-Aldrich, St. Louis, MO, USA), 
cells were incubated at 37°C for four hours. Aft  er incubation, 
the cells in the upper surface of the membrane were removed 
with cotton swab and the cells that migrated to the lower 
surface of the membrane were fixed and stained with Diff 
Quik Solution (Sysmex, Kobe, Japan). Th   e migrated cells on 
the lower surface of the membrane filter were scored from 
nine random fi  elds under microscopy (200× magnifi  cation). 
Experiments were performed in triplicate and repeated thrice.
Wound-healing assay
One day aft  er the transfection of NUPR1 siRNA into cells 
in a 6-well plate, cells were transferred and cultured to a 48-
Fig. 1. Nuclear protein-1 (NUPR1) was over-expressed in cholangiocarcinoma. Immunohistochemistry was carried out using cholangiocarcinoma 
patient tissues (n=10) to examine the expression of NUPR1. Representative stainings from normal (A) or cancerous areas (B-D) are presented. 
Hematoxyin and eosin  staining was used for counterstaining. Scale bars=50 μm (A-D). Anat Cell Biol 2012;45:17-25 Ki-Sun Kim, et al 20
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well plate until confluent. Three hours following treatment 
with mitomycin C at 5 μg/ml (Sigma-Aldrich), cells were 
scratched using 200 μl yellow tips and moved to fresh media 
to incubate for 24 hours.
Matrigel invasion assay
As described by Baek et al. [29], following two days of 
transfection with SCR or NUPR1 siRNA into cells, transfected 
cells were seeded to a 24-well BioCoat Matrigel chamber 
inserts (BD Biosciences, San Jose, CA, USA). Eighteen hours 
aft  er treatment with mitomycin C at 5 μg/ml (Sigma-Aldrich), 
the cells on the insert insides were removed with cotton tips, 
and the invaded cells on the insert outers were visualized 
using hematoxylin/eosin staining.
Data analysis
All data are presented as means±SD. All experiments were 
repeated at least four times. Th  e  diff  erence between the mean 
values of the two groups was evaluated using Student’s t-test 
(unpaired comparison). For comparison of more than three 
groups, we used one-way analysis of variance (ANOVA) test 
followed by Tukey’s multiple comparison. A P-value of <0.05 
was considered statistically signifi  cant.
Results
First of all, we examined the expression status of NURP1 
in cholangiocarcinoma patients’ tissues (n=10). Normal areas 
in patient tissues were used as a control. Low level of NUPR1 
expression was observed in the nuclei of normal bile duct 
cells (Fig. 1A). However, in cancerous areas, signifi  cant over-
expression of NUPR1 was observed (Fig. 1B-D).  
Next, we studied the functional significance of NUPR1 
in cholangiocarcinoma cells. To examine the role of NUPR1 
in HuCCT1 cholangiocarcinoma cells, we knock-downed 
it using the specific siRNA. RT-PCR or western blotting 
(Fig. 2) showed the RNA and protein level of NUPR1 was 
significantly reduced by NUPR1 siRNA. To reveal the role 
of NUPR1 in the proliferation of cholangiocarcinoma cells, 
we performed WST-1 survival assay, three and seven days 
after knock-down. In the presence of 1% or 10% FBS, 100 
nM NUPR1 siRNA reduced the proliferation of HuCCT1 by 
23.2% and 17.8% respectively compared to SCR siRNA seven 
days aft  er knock-down (Fig. 3).
To examine the role of NUPR1 in the migration of HuCCT1 
cholangiocarcinoma cells, we performed Boyden chamber 
assays (Fig. 4) and wound healing assays (Fig. 5). To rule 
out the eff  ect of proliferation on migration assays, we added 
mitomycin C into the media. In the Boyden chamber assay, 
NUPR1 siRNA reduced EGF- or FBS-induced migration by 
21.1% and 34.6% respectively, compared to SCR siRNA (Fig. 
4). Moreover, we also observed similar eff  ects of NUPR1 siRNA 
on FBS-induced migration of SNU1196 cholangiocarcinoma 
cells (data not shown). Th   is reduction of migration by NUPR1 
siRNA was further confi  rmed by wound healing assays (Fig. 
5). 
Finally we examined the role of NUPR1 in the invasion of 
HuCCT1 cholangiocarcinoma cells using Matrigel invasion 
assays. In this, NUPR1 siRNA reduced EGF- or FBS-induced 
invasion by 75.4% and 41.4% respectively, compared to SCR 
siRNA (Fig. 6). Moreover, we also observed a similar effect 
Fig. 2. Nuclear protein-1 (NUPR1) siRNA specifi  cally down-regulated NUPR1 expression in HuCCT1 cholangiocarcinoma cells. Th  e  mRNA 
level of NUPR1 was reduced by siRNA (A). Th   e protein level of NUPR1 was also reduced by siRNA (B). Protein and RNA were extracted two 
days aft  er transfection with indicated concentrations of the siRNA. Th   ree independent experiments were repeated. β-actin and α-tubulin were used 
for normalization of RNA and protein loading respectively. SCR, scrambled.NUPR1 in cholangiocarcinoma cells
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Fig. 3. Effects of knock-down of nuclear protein-1 (NUPR1) on proliferation of HuCCT1 cholangiocarcinoma cells. Cell proliferation was 
measured three and seven days aft  er the siRNA transfection using WST-1 assay. In the presence of 10% (A) or 1% fetal bovine serum (FBS) (B), 
proliferation was examined. Data show the means±SDs of three independent experiments performed in quintuplicate (*P<0.05). SCR, scrambled.
Fig. 4. Nuclear protein-1 (NUPR1) 
af  fected epidermal growth factor 
(EGF)- or serum-induced migration of 
HuCCT1 cholangiocarcinoma cells. To 
examine effects on migration, Boyden 
chamber assays were performed. Two 
days after siRNA transfection, 5×10
4 
cells were seeded into Boyden chambers. 
Addition of 100 nM EGF or 10% fetal 
bovine serum (FBS) into lower but 
not upper Boyden chambers induced 
migration of the cells. To rule out eff  ects 
of proliferation, mitomycin C (5 μg/ml) 
was added. Four hours later, cells were 
fixed, stained with Diff-quik solution 
and pictured. Th   e representative staining 
of migrated cells is presented (A). Scale 
bar=50 μm. (B) Migrated cells were 
counted and the data are presented as 
a graph. Data show the means±SDs 
of three independent experiments 
performed in triplicate (*P<0.05). SCR, 
scrambled. Anat Cell Biol 2012;45:17-25 Ki-Sun Kim, et al 22
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Fig. 5. Nuclear protein-1 (NUPR1) af-
fected epidermal growth factor (EGF)- 
or serum-induced migration of HuCCT1 
cholangiocarcinoma cells. To examine 
the eff  ects on migration, wound healing 
assays were performed. To rule out eff  ects 
of proliferation, mitomycin C (5 μg/
ml) was added. A day after scratch with 
a yellow tip, migration was documented. 
Three independent experiments were 
carried out. FBS, fetal bovine serum; 
SCR, scrambled.
Fig. 6. Nuclear protein-1 (NUPR1) 
aff  ected epidermal growth factor (EGF)- 
or serum-induced invasion of HuCCT1 
cholangiocarcinoma cells. To examine 
the eff  ects on invasion, matrigel invasion 
assays were performed. Two days after 
siRNA transfection, 5×10
4 cells were 
seeded into matrigel-coated transwells. 
To rule out effects of proliferation, 
mitomycin C (5 μg/ml) was added. 
Eighteen hours later, the cells were fi  xed, 
stained with Diff-quik solution, and 
pictured. The representative staining 
of invaded cells is presented (A). Scale 
bar=50 μm. (B) Invaded cells were 
counted and the data are presented as a 
graph. Data show means±SDs of three 
independent experiments performed in 
triplicate (*P<0.01). FBS, fetal bovine 
serum; SCR, scrambled. NUPR1 in cholangiocarcinoma cells
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of NUPR1 siRNA on FBS-induced invasion of SNU1196 
cholangiocarcinoma cells (data not shown). 
Discussion
Th   e extensive invasion of cholangiocarcinoma cells greatly 
affects the prognosis of patients. Molecular understanding 
about the motility of cholangiocarcinoma cells will improve 
diagnosis and therapy. In the present study, we documented 
over-expression of NUPR1 in cholangiocarcinoma and its role 
in cell proliferation and motility.
The over-expression of NUPR1 in cholangiocarcinoma 
patient tissues was presented in the current study for the fi  rst 
time. NUPR1 has been shown to be over-expressed in various 
cancers including those of the pancreas, breast, pituitary and 
thyroid. Interestingly, the expression of NUPR1 in thyroid 
cancers was directly linked to lymph node metastasis [24]. 
In addition, cellular localizations of NUPR1 were related to 
biological characteristics of papillary carcinoma. In aggressive 
tumors, NUPR1 is localized in the cytoplasm, whereas in less 
aggressive tumors, it in the nucleus [1, 30]. In future study, 
the relationship between NUPR1 over-expression and patient 
prognosis needs be examined. 
There have been contradictory reports about the role of 
NUPR1 in cell proliferation. Its over-expression in Cos-7 or 
AR4-2J cells promoted cell proliferation [4]. Knock-down 
of NUPR1 in LβT2 cells decreased in vivo tumorigenicity 
and increased expressions of cycle regulators such as p21 
and p57 [31]. Moreover, NUPR1 siRNA decreased colony 
formation and tumorigenicity of pancreatic cancer-derived 
cells [20]. However NUPR1 over-expression decreased the 
growth of prostate tumors in vivo [32, 33]. Moreover, NUPR1 
negatively regulated the cell cycle and promoted myogenic 
differentiation in C2C12 myoblasts [34, 35]. One suggested 
mechanism by which NUPR1 may regulate cell proliferation 
is through  interaction with Jab1, a component of the COP9 
signalosome complex. Th   e NUPR1 and Jab1 complex induces 
translocation of p27 from the nucleus to the cytoplasm where 
it is degraded [36]. In the present study, NUPR1 siRNA 
slightly reduced proliferation of cholangiocarcinoma cell 
lines. 
Th   e role of NUPR1 in the motility of cancer cells was fi  rst 
described in pancreatic cancer-derived cells [20]. Knock-
down of NUPR1 in pancreatic cancer cells in vitro decreased 
migration and invasion while increasing cell adhesion. 
More  over, its over-expression showed opposite effects. 
This suggested that CDC42 might mediate the regulation 
of motility by NUPR1. In the current study, we showed for 
the first time that NUPR1 siRNA decreased migration and 
invasion of cholangiocarcinoma cell lines. In future study, the 
underlying mechanisms through which NUPR1 regulates cell 
motility need be examined.
In the present study, FBS-induced migration was more 
sensitively inhibited by NUPR1 siRNA than was EGF-induced 
migration. However, EGF-induced invasion was more 
sensitively inhibited by NUPR1 siRNA than was FBS-induced 
invasion. Molecules that can degrade the extracellular matrix 
also contribute to the invasion process of cancer cells in 
addition to those molecules which regulate the migration of 
cancer cells [37]. Therefore the different sensitivity to FBS 
or EGF in migration and invasion may involve different 
regulation of the molecules involved. Further studies need to 
be conducted to examine this diff  erent sensitivity.
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